Weight-Loss Drugs Could Hit Medicare for $50 as CMS Upends Coverage Rules
WASHINGTON, D.C. — In a move that could reshape how obesity and metabolic disease are treated nationwide, federal health officials unveiled a new strategy to bring high-profile GLP-1 weight-loss drugs …
Weight-Loss Drugs Could Hit Medicare for $50 as CMS Upends Coverage Rules Read More